Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/10/2010WO2010064806A2 Composition for preventing adhesion
06/10/2010WO2010064792A2 Pharmaceutical compositions containing fucoidan for stimulating and activating osteogenesis
06/10/2010WO2010064790A1 Ecklonia cava-derived phloroglucinol derivatives having inhibitory activities against hiv-1
06/10/2010WO2010064785A2 Method for selectively crystallizing a z isomer of iopromide
06/10/2010WO2010064762A1 Anticancer drugs containing micrornas as active ingredients, and method for preparing same
06/10/2010WO2010064750A1 Phloroglucinol derivatives from ecklonia cava having anti-hiv-1 inhibitory activity
06/10/2010WO2010064745A1 Acylamides inducing apoptosis of cancer cells
06/10/2010WO2010064737A1 Heterocyclic compound and use of the same
06/10/2010WO2010064736A1 Therapeutic agent for cancer
06/10/2010WO2010064735A1 Quinolone compound and pharmaceutical composition
06/10/2010WO2010064722A1 Benzothiazole derivatives as anticancer agents
06/10/2010WO2010064714A1 Nutrient composition
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064705A1 Novel 7-substituted dihydropyranopyrimidine derivative having h4 receptor antagonistic activity
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064688A1 Pyrimidine derivatives, horticultural insecticides comprising said derivatives and method of use thereof
06/10/2010WO2010064665A1 Therapeutic agents
06/10/2010WO2010064636A1 Ophthalmic composition
06/10/2010WO2010064633A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
06/10/2010WO2010064611A1 Heterocyclic compound and use thereof
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064441A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
06/10/2010WO2010064422A1 Method for killing tumor by photosensitization treatment under conditions where histone is highly acetylated
06/10/2010WO2010064324A1 Intravascular indwelling catheter lock solution containing acetic acid and container containing the same
06/10/2010WO2010064300A1 Composition for treatment of esophageal cancer
06/10/2010WO2010064261A1 Synergistic combinations of aztreonam with the carbapenems meropenem and ertapenem
06/10/2010WO2010064248A2 Methods of diagnosing and treating motor neuron diseases
06/10/2010WO2010064242A1 Brassinosteroids for use in treating prostatic hyperplasia and androgenic alopecia
06/10/2010WO2010064210A1 Combination of lycopene, polyphenol, and vitamins for the care of keratin material
06/10/2010WO2010064111A1 Tnik inhibitor and the use
06/10/2010WO2010064100A1 Baclofen gastroretentive drug delivery system
06/10/2010WO2010064047A1 Use of sabcomeline for the treatment of add or adhd
06/10/2010WO2010064020A1 Imidazopyridine compounds
06/10/2010WO2010064018A1 Methods and reagents for diagnosing atheroma
06/10/2010WO2010063997A1 Telmisartan formulations
06/10/2010WO2010063996A2 Antibacterial compounds
06/10/2010WO2010063995A2 Telmisartan with diuretic formulations
06/10/2010WO2010063953A2 Novel amino c-xyloside compounds, and cosmetic use
06/10/2010WO2010063948A2 Novel c-xyloside oxime compounds, and cosmetic use
06/10/2010WO2010063910A1 Use of geranyl-geranyl transferase in treating spinal cord lesions
06/10/2010WO2010063876A1 Imidazopyridine derivatives which inhibit the secretion of gastric acid
06/10/2010WO2010063847A1 Compositions for potentiating apoposis signals in tumour cells
06/10/2010WO2010063824A1 Novel composition for treatment of essential thrombocythemia
06/10/2010WO2010063802A1 3, 4-di-substituted cyclobutene- 1, 2 -diones as cxcr2 receptor antagonists
06/10/2010WO2010063784A1 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
06/10/2010WO2010063774A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/10/2010WO2010063773A1 Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
06/10/2010WO2010063724A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
06/10/2010WO2010063721A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/10/2010WO2010063698A1 Treatment of oncological diseases
06/10/2010WO2010063696A1 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
06/10/2010WO2010063675A1 Fully human influenza m2 specific antibodies
06/10/2010WO2010063666A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010WO2010063663A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063662A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063638A1 Bis [o-(14-benzoylaconine-8-yl)] esters
06/10/2010WO2010063634A1 Pyrrolopyrazinyl urea kinase inhibitors
06/10/2010WO2010063630A2 Pancreatic tumour treatment
06/10/2010WO2010063610A1 Pyridazinone derivatives
06/10/2010WO2010063493A1 Oral dosage forms of bendamustine
06/10/2010WO2010063488A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage
06/10/2010WO2010063487A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
06/10/2010WO2010063486A1 Use of eltoprazine for the treatment of l-dopa-induced dyskinesia
06/10/2010WO2010063476A2 Solid dosage forms of bendamustine
06/10/2010WO2010063472A1 Methods for preventing or reducing colon carcinogenesis
06/10/2010WO2010063471A1 Inhibitors of hif-1 protein accumulation
06/10/2010WO2010063470A2 Methods for preventing or reducing carcinogenesis or oxidative stress
06/10/2010WO2010063415A1 Skin whitener
06/10/2010WO2010063402A1 Substituted benzyl and phenylsulfonyl triazolones, and use thereof
06/10/2010WO2010063352A1 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
06/10/2010WO2010063292A1 Nalmefene hydrochloride dihydrate
06/10/2010WO2010063163A1 A patch of antiemetic agent
06/10/2010WO2010063114A1 Method and apparatus for packaging and dispensing pharmaceuticals
06/10/2010WO2010063080A1 Amphiphile prodrugs
06/10/2010WO2010063069A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
06/10/2010WO2010045601A3 Synergistic combination of sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
06/10/2010WO2010045435A3 Salicylic acid composition
06/10/2010WO2010045415A3 Topical nsaid compositions having sensate component
06/10/2010WO2010043976A3 Highly pure ranolazine or a pharmaceutically acceptable salt thereof
06/10/2010WO2010039827A3 Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists
06/10/2010WO2010037728A3 Formulations comprising ezetimibe
06/10/2010WO2010036947A3 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
06/10/2010WO2010036404A3 Novel retinamide retinoic acid metabolism blocking agents
06/10/2010WO2010034853A8 Utilization of xylitol or its derivatives for taste-masking chemotherapy drugs of the quinolone-o-naphthyridone carboxylic acid group administrated in food intended for pigs
06/10/2010WO2010034497A3 Compacted cinacalcet
06/10/2010WO2010033986A3 Dna cytosine deaminase inhibitors
06/10/2010WO2010032875A3 Heterocyclic carboxamide compounds
06/10/2010WO2010032093A3 Cytostatic composition
06/10/2010WO2010031832A3 Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
06/10/2010WO2010030132A3 Purification method for adefovir dipivoxil
06/10/2010WO2010029378A3 Anti-protozoa compounds
06/10/2010WO2010029131A9 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
06/10/2010WO2010028192A8 Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
06/10/2010WO2010028134A3 Treatment of neurological disorders using huperzine
06/10/2010WO2010028130A3 Antidepressant compounds
06/10/2010WO2010027875A3 Compounds that modulate intracellular calcium
06/10/2010WO2010025370A3 Preparation of ranolazine
06/10/2010WO2010025251A3 Materials and methods for modulating appetite, weight gain and adhd using varenicline
06/10/2010WO2010022238A3 Anti-flavivirus therapeutic
06/10/2010WO2010021934A3 Azaindole inhibitors of iap
1 ... 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 ... 7860